Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

Members of Congress have raised concerns about the potential sale of popular genetic testing company, 23andMe, and its impact on user data privacy.

Lawmakers are demanding answers from the company on how it plans to protect the sensitive genetic information of millions of customers in the event of a sale.

With growing concerns over data breaches and misuse of personal information, Congress is taking a closer look at the implications of allowing a company like 23andMe to be sold to a third party.

Privacy advocates are also urging lawmakers to ensure that any sale of 23andMe includes strict privacy protections and safeguards for user data.

The sale of 23andMe could have far-reaching consequences for the future of genetic testing and the protection of individual privacy rights.

Congressional hearings have been scheduled to address these concerns and to hold 23andMe accountable for its data privacy practices.

Many are watching closely to see how Congress will handle this issue and what actions will be taken to protect consumer privacy in the digital age.

As the debate heats up, the future of 23andMe and the data privacy of its customers hangs in the balance.

Stay tuned for updates on this developing story as Congress continues to demand answers on data privacy ahead of the 23andMe sale.